Authors' reply: PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?

Alberts, Ian; Seide, Svenja Elizabeth; Mingels, Clemens; Bohn, Karl Peter; Shi, Kuangyu; Zacho, Helle D; Rominger, Axel; Afshar-Oromieh, Ali (2021). Authors' reply: PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer? European journal of nuclear medicine and molecular imaging, 48(8), pp. 2307-2308. Springer 10.1007/s00259-021-05376-2

[img] Text
Alberts2021_Article_AuthorsReplyPSMA-PETIsTheTimeT.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Author holds Copyright

Download (182kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Alberts, Ian Leigh; Mingels, Clemens; Bohn, Karl Peter; Shi, Kuangyu; Rominger, Axel Oliver and Afshar Oromieh, Ali

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1619-7089

Publisher:

Springer

Language:

English

Submitter:

Daria Vogelsang

Date Deposited:

19 Jan 2022 17:01

Last Modified:

19 Jan 2022 17:01

Publisher DOI:

10.1007/s00259-021-05376-2

PubMed ID:

33948676

BORIS DOI:

10.48350/163975

URI:

https://boris.unibe.ch/id/eprint/163975

Actions (login required)

Edit item Edit item
Provide Feedback